Insider · CIK 0001704540
Wilbur H Smith III
Files at AHR (American Healthcare REIT, Inc.). First filing -, latest -.
In brief
Wilbur H Smith III files SEC Form 4 as director at AHR (American Healthcare REIT, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Wilbur H Smith III has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +2,594 | $0.00 | $0 | 35,013 | Jun 26, 2026 |
| Jun 25, 2025 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +3,042 | $0.00 | $0 | 32,419 | Jun 27, 2025 |
| Nov 7, 2024 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +3,610 | $0.00 | $0 | 29,377 | Nov 12, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Class T Common Stock | -18,360 | - | - | 0 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Common Stock | +18,360 | - | - | 25,767 | Aug 7, 2024 |
| Feb 9, 2024 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +7,407 | $0.00 | $0 | 7,407 | Feb 13, 2024 |
Questions about Wilbur H Smith III
Answered from the filings on this page, as of the latest one.
Is Wilbur H Smith III buying or selling?
Wilbur H Smith III has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Wilbur H Smith III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wilbur H Smith III has 0.
Where does Wilbur H Smith III file Form 4?
Wilbur H Smith III has filed Form 4 at AHR (American Healthcare REIT, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.